Evidence map›Paper›PMID 29954326›Full record

ArticleBMC gastroenterology2018

The values of applying classification and counts of white blood cells to the prognostic evaluation of resectable gastric cancers.

Yin-Ling Wang, Xin-Xin Ge, Yi Wang, Meng-Dan Xu, Fei-Ran Gong, Min Tao, Wen-Jie Wang, Liu-Mei Shou, Kai Chen, Meng-Yao Wu and 1 more

Open access · goldAbstract read
In one paragraph

Article in BMC gastroenterology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 19 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Yin-Ling WangDepartment of Oncology, the First Affiliated Hospital of Soochow University, Suzhou, 215006, China.
Xin-Xin GeDepartment of Oncology, the First Affiliated Hospital of Soochow University, Suzhou, 215006, China.
Yi WangDepartment of Oncology, the First Affiliated Hospital of Soochow University, Suzhou, 215006, China.
Meng-Dan XuDepartment of Oncology, the First Affiliated Hospital of Soochow University, Suzhou, 215006, China.
Fei-Ran GongDepartment of Hematology, the First Affiliated Hospital of Soochow University, Suzhou, 215006, China.
Min TaoDepartment of Oncology, the First Affiliated Hospital of Soochow University, Suzhou, 215006, China.
Wen-Jie WangDepartment of Oncology, the First Affiliated Hospital of Soochow University, Suzhou, 215006, China.
Liu-Mei ShouDepartment of Oncology, the First Affiliated Hospital of Zhejiang Chinese Medicine University, Hangzhou, 310006, China.
Kai ChenDepartment of Oncology, the First Affiliated Hospital of Soochow University, Suzhou, 215006, China. kaichen@suda.edu.cn.
Meng-Yao WuDepartment of Oncology, the First Affiliated Hospital of Soochow University, Suzhou, 215006, China. mywu@suda.edu.cn.
Wei LiDepartment of Oncology, the First Affiliated Hospital of Soochow University, Suzhou, 215006, China. liwei10@suda.edu.cn.ORCID http://orcid.org/0000-0002-0746-1091
Soochow University · CNZhejiang Chinese Medical University · CN

Funding

National Natural Science Foundation of China 81272542National Natural Science Foundation of China 81472296National Natural Science Foundation of China 81602091
6 · The paper itself

Abstract

backgroundThe classifications and counts of white blood cells (WBCs) have been proved to be able to be used as prognostic markers in cancer cases. The present study investigated the potential values of the classifications and counts of WBC, including lymphocyte (LY), monocyte (MO), neutrophil (NE), eosinophil (EO), and basophil (BA) in the prognosis of resectable gastric cancers (GCs).

methodsThis retrospective study recruited 104 resectable GC cases which were pathologically confirmed. The patients were divided into two groups according to the median pre-treatment values. To evaluate the changes in WBC counts and classification after treatment, we introduced the concept of post/pre-treatment ratios (≤ 1 indicated count was not increased after therapy, while > 1 suggested increased count).

resultsPre-treatment NE and total WBC counts were negatively correlated with overall survival (OS). Surgery significantly decreased the level of NE count, but increased the level of EO, whereas had no effect on the levels of LY, MO, BAor total WBC. Adjuvant chemotherapy significantly decreased the level of BA. Whole course of treatment (surgery combined with adjuvant chemotherapy) had no significant effect on the counts of LY, MO, NE, EO, BA or total WBC. Post/pre-treatment ratios of LY, MO NE, EO, BA and total WBC levels had no effects on OS. Univariate analysis indicated that AJCC stage (III) and higher level of pre-treatment total WBC count were prognostic factors affecting OS. Multivariate Cox regression analysis revealed that AJCC stage (III) and higher level of pre-treatment total WBC count were independent prognostic factors.

conclusionsPre-treatment NE count and pre-treatment total WBC count may be potential prognostic factors for the prognostic evaluation of GCs.

Indexed as

AdultAgedChemotherapy, AdjuvantFemaleHumansLeukocyte CountMaleMiddle AgedPrognosisRetrospective StudiesStomach NeoplasmsSurvival AnalysisGastric cancer (GC)Overall survival (OS)PrognosisWhite blood cell (WBC)

Identifiers

PMID29954326
PMCPMC6022412
OpenAlexW2810743218

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.